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In contrast to the TGF-fH and 132 isoforms, TGF-f33 
has shown the ability to downregulate scarring and 
fibrosis in vivo under certain experimental conditions. 
In this study, we determ~ned the direct effects of 
TGF-f33 on cultures of human dermal fibroblasts. 
TGF-f33 (0.1 to 100 pg per ml) increased DNA synthe-
sis up to 50% (p < 0.01, r = 0.970), collagen protein 
synthesis up to 200% (dose range of 0.1 to 5 ng per mI, 
p < 0.001, r = 0.990), and increased 0'1(1) procollagen 
mRNA levels (r = 0.999), with maximal effects (200% 
of control) observed by 24 h. Collagen lattice con-
traction was increased by more than ~O% in response 
fo TGF-f33 (p < 0.001), and to a similar extent as the 
TGF-f31 isoform. Stimulation of collagen synthesis 
and of 0'1(1) procollagen mRNA levels in response to 
TGF-f33 was partially blocked by a TGF-f31-specific 
T he transfoflll.ing growth factor-{3's (TGF-,B's) are a famj.IY. of multifunctional peptides that regu .. late cell growth and dIfferentlatlOn through th e actIOn of distin ct and common cellular receptors (Roberts and Sporn , 1990, 1993). TGF-{3's are important in deve l-
o pmental processes and in regulating the immune response and play 
a fundamental ro le in extrace Uular matrix fonnation (Roberts and 
Sporn, 1993) . They have been showp to accelerate many of the 
parameters of tissu e repair (Roberts, 1995), and their pathogenic 
role in th e development of fibrosis is becoming increasingly clear 
(Bord er and Noble, 1994). TGF-{31 was purified and characterized 
in 1983 as a homodime..i c, 25 kDa protein. More recently, TGF-{3's 
2 through 5 have been discovered and characterized at the protein 
and mol ecular level. Presently, only the TGF-{31, {32, and {33 
isoform s have been isolated from human sources (Cox, 1995) . All 
m embe rs of the TGF-{3 family are synthesized as a laJ'ge precursor 
protein , which is proteolytica lly cl ea ved to yield a mature carbmcy-
terminal unit of 11 2 amino acids (Roberts, 1995) . The TGF-{3 
pe ptides have a high (70-80
'
%) degree of shared seq uen ce homol-
ogy in the carboxy-tenninal mature region, and th e sequence of all 
three iso forms is almost tota ll y conseJ'ved across species (Roberts. 
1995) . Intel'estin gly, however, th e N-terminal pro-domain of the 
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anti-sense oligonucleotide but was still detectable 
(35% greater than baseline) when TGF-f33 was added 
to dermal fibroblasts from TGF-f31 knock-out mice. 
In contrast with these stimulatory effects, however, 
downregulation of 0'1(1) procollagen, 0'1(111) pro col_ 
lagen, and TGF-f31 mRNA levels toward baseline 
occurred when TGF-f33 (0.1 to 5 ng per mI) was added 
sinlultaneously and in combination with TGF-f31. We 
conclude that stinlulation of collagen synthesis by 
TGF-f33 occurs through TGF-f31-dependent and in-
dependent pathways. By downregulating the re-
sponse to TGF-f31 and by shifting from one pathway 
to the other, TGF-JH can dampen and provide finc-
tuning to the overall TGF-f3's induced program of 
collagen deposition. Key //lords: fibroblastsllibrosisliso-
jol'ltlslswrl'illg. ] Invest Derlllatol 108:258-262, 1997 
TGF-{33 isofor11l is quite distin ct fro m the othe r two m;lmmalian 
isoform s, altll ough hi ghl y co nserved (80-90'/"0) ac ross species . 
T he TGF-{31, {32. and {33 iso fo rms arc difle re n tia ll y regul;lted, 
bu t th eir diHe rent e ffects and in tenlctions arc not clear. Altho ugh it 
has often been stated that the three peptides He egui val e llt in m ost 
assays , difFe rences ha ve been noted in th e loca liza tion and diso'ibu-
tion of the three isofonns in several tissues durin g embryogenesis. 
fibro sis, and wound healing (Gra yca r cl nl, 1989; I.l..oberts and 
Sporn , 1990). A recen t repo rt sugges ts a markedl y difFerent eHecr of 
TGF-{33 fro m the other isoform s. In that stud )" inj ectio n of 
T GF-{33 into experimental murine wounds decreased scarring, the 
oppos ite of what was. in variabl y observed w ith inj ection o f the {31 
or {32 isoforms (Shah cl nl, 1995). It is un clear wheth er thjs 
paradoxica l action is due to difFerenti al effects of TG F-{3 isoforms 
on the syn thesis o f ex trace llular matri x by tibroblasts. T herefore . 
we decided to investigate th e direct eHect o f TGF-{33 and irs 
in teractions w ith TGF- {31 o n co ll agen synthesis in human dermal 
fibrobl asts. The results shown he re indicate that TGF-{33 stimulates 
collagen syn thes is th ro ugh TGF-{3 ·1- depc nd ent and ind ep endent 
mechanism s and tha t it is 'Ib le to contro l and bl oc k rh e stim ul arory 
efFects of TG F-{31. 
M AT ER.lALS AND METH ODS 
Dermal F ibrobla st C ultures C ulture, of human denll ,, 1 fibroblasts 
were est:lbli shed alld main ta in ed. as prev iously described . fi'olll foreskin of 
hea lthy Il co llatal illf:lllts (F,,)all ga C/ fll , 191) '1). Passages 3 to 8 were used 
t1l.ro ugho ll[ the ex pc rirn c l1ts. C ultures were iniriated fro lll cxplants and 
passaged ill T-7 5 Aasks (C ornillg G lass Works. COmiJlg. NY) and seeded ill 
Dulbccco mo difi ed Eagle 's Ill edium (DMEM. fi'om S.ig1l1a, St . Lo uis, M O) 
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F ig ure 1. TGF-{B stimu-
lates DNA synthesis in hu-
man dermal fibroblasts. 
Cells were exposed [0 increas-
ing concentrations of TG F-/33 
for 24 II befo re Ill CaS lIn.:: 1l1 CntS 
were made. R.esul t represent 
the lI1 ea n ± SJ) li'om quadru-
plicate we ll s. 
and 10% fetal bovine se rum (FBS) (GJl3CO laborato ries, Grand Island, 
NY). Fibroblasts we re grown and kept at 37°C in 5')1" CO2 , 95% air. 
Experiments were done by washing mono layers with plai n OMEM and 
incubating the cultllres 30 lI1in w ith 0. 1 'y" bo vine se rulll albumin (S igma). 
Serum-free medium (A IM-V . G Il3CO BIU-, Gaithersburg, MD) was used 
ill experiments designed to determ in e diffe rentia l enects ofTGF-/3 iso fonns. 
For the purpose o f es tabli shing cultures of TGF-/3 I knock-out dermal 
fi broblasts, skin fi'o lll TGF-(3 1 knock-out mice (Kulkarni eI aI, 19(3) and 
control litterm at"s was obtained fr0 1l1 Dr. Ani ta R.oberts (National Cancer 
In stitute. Laboratory of C hemoprevelltion). Dermal fIbroblasts cultured 
from mouse skin were maintained in DM EM plos 10'1., HlS until actual 
experiments, at w hich time cultures were washed ex tensive ly with DMEM, 
an d serul11 -fj'ce m edium (A IM-V) was added. 
[JH]Thymidine Uptake Fibroblasts were seeded at 30.000 ce lls per 2 
cm
2 
well s in DMEM sllppk l11 cnted with 10'1'1, FBS. Aft.er 24 11 , rnono layers 
were washed with phospha te huWe reci sa lin e (G IDCO HI'lL) and the 
medium was replaced with I 1111 of DM EM and IJ.S% 1-lyClone serum 
(HyC lone Laboratories, Lo[,:",. UT) . After an acid iti on;r1 24 h. Illono laye rs 
were washed with phosphate-buW(,red sa lin c and ill clIba ted lu r 24 h with I 
mJ ofDMEM. 0.5% HvcJo ll e se rulll. with. alld withom TGF-/3"s. Next cia)' . 
cultures WC re each pu lsed I'i) r 4 h w ith 2 ,..,Ci o ( lII eth yl- I' Hl rhYllIidi ne (86 
C i/ mmol. Alllershalll Corp .. Arlington Heights. IL). Measurelllell ts of 
['H lthymidinc up take were dOlle as previously described (Takagi c/ aI, 
1995). 
RNA Extraction a nd Northern Analy.i. Tota l cel lular R.NA from 
ce Us was isola ted by extraction in guanidilllll isothioc)' al1<ltc. using the 
method of C hol11czynski and Sacehi ( I Yt!7). Experimental conditions for 
RNA elec trop ho resis. blotting, and hybridization were identi cal to those we 
have recentl y described (Takagi cl aI, 1995). T he fo llowillg eDNA probes 
were used: a 1.5 kb ECld\'1 tragmellC ofcDNA fi'o l1l th e o riginal c10De 1-11'677 
fo < the 0" (I) procollagell chaill (C hu el al. 1982); a 1.4-kb Pstl (j'ag nre llt of 
the cD NA clone pH 111 33 coding n:gion for the (Y 1 (111) proco llagen chain 
(M isku lin ('1 aI, 1986); a I . I-kb te a R. I fragment o f tire TGF-/31 eD NA 
(DerYlIck CI ,, / , 1985). Glyce raldehydc-3-ph osphatc dehydrogenase 
(GA PDH) cD NA was from the Alllerican Tissue C ul ture Coll ection 
(A TCC, R.ockvi ll e , M 0) . Pro bes were label ed with 321' by random priming 
(2 X 10" cplll / ,..,g) and used lo r Nonhenr blot analysis as previously 
describcd (Fa langa c l (/1, 19(3). 
Anti-Sense Oligonucleotides We lI"ed 0. 1 to 10 ,..,M of a TGF-/3 1 
19' mcr ami-sc lISe o li gollllcleotide (5' gAg ggC ggC A Tg ggg gAg g 3 ' ), 
w h.i ch overlaps the prOlllote r and tr;lIlScriprio ll al start site of the TGF-/31 
gene. This sallle sequ ellce . which is speciti t" ft,.. d,e TGF-{n isoform , Ir as 
been used successfull ), b), others to block TGF-/3 1 trallScription ;11 ,,;"" 
(Brun ct CI ai, 1995). Sense oligo llucleotide served as all :rddirio,,:r l con trol. 
Measurcn"l cnts of Collagenous Protein Cells were seeded in 96-wdl 
plates alld cultured to " conllue"t " lO llo l;l ),e r ill 0.2 1111 of DMEM 
supplemented with 10% FBS. After a 4S-h illcubation to obta ill confluent 
c ultures, the Illo llola),c rs w e re w ashed twice w ith D M EM and ill cubated 30 
min with DMEM suppiclllellted with 0.1 % BSA. Afte r washillg wi th 
DMEM, mcdiul1l was rcpi:! ced to 0.2 1111 ofDMEM, 3% HyClo l1 e se rUI1l , 50 
j.Lg of freshly prepared ascorhic ;Icid per 1111 . and 2 ,..,C i of I' HI-p ro line (99 
-- TGF-bettl 3 {ngfmq--
Figure 2. TGF-(B in-
creases colla genous pro-
tein production. I' Hlproline 
in cO fponlti o n \vas 111C3SllfCd 
48 h afte r the :Iddition 0 1' in-
crc;] sing COIl CCIHratiolls of 
T G F-/33 to 1"1111:111 dermal fi-
brobJ:.sts. Resul ts represent 
the Ill ean ± SO (i'01ll five we lls 
for each cxperimental group . 
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Figure 3. TGF-{:I3 stimu-
lates coUagen gel contrac-
tion. Gels cOllsistillg of type I 
collagclI and human derm:r1 
fib ro blasts were incubated in 
the presence of cOll trol media 
(MCDB 105) with or without 
TGF-/31 or TGF-133. G' I di-
arnc tcr w as 1l1casllred daily . 
T he results arc tl, ' mean ± SO 
fro l11 quadruplicate wells. 
DAYS 
o Qln',01 
C i/ mll'lo l, Amersham Corp.) with or without TGF- J3's. Afte r 24 h, IJH1-
pro line incorporation into pepsin-resistant sa lt-precipitab le extrace llular 
co ll agen was determined as prev iously described (Webster and H;1rvcy. 
1979; T akagi et aI, J 995). R esults were expressed as counts per minute 
(CPM). 
Collagen Gel Contraction T hese were prepared as previously de-
scribed (Tings trolll 1'1 " ,. 1992; Da ns and IsscroW. 1994; Takagi cl al. 1995). 
Briefl y. 35-1111'11 weUs of six-well plates were pre-treated overnight with 4 ml 
of DMEM pcr well supplemented with 2% BSA to prevent ge l attachment 
to the we lls, then washed twice with phosphate-buWered sa line . A so lu tion 
of bovine collagen type I and III (Vitrogen 100. Celtrix Labora tories, Palo 
Alto, CAl was mixed with 0.2 M HEPES buRer, pH 8.0 (S igma) and 2 X 
MCD B 105 (ratio of 4 : I :5) . After warmi.n g the mixture to room te mpera-
ture, 200 ,..,1 of a suspens ion of 350,000 ce lls per rnl o f human neona ta l 
foreskin fibrob lasts in MC DU '105 were added pcr ml, and 2 ml Of tllC final 
SUS}) ' l1sio ll \",ere po ured into pre-treated w e ll s <lnd in cubated for I h at 37°C 
in 95% air and 5% CO2 , Subsequently, I 1111 of MC Dl3 105 with o r without 
15 ng of TGF-/3 isofo rms pcr ml were added to each gel. As gels were not 
pm'(ectl y round, ge l contraction was measured dai ly by using the mea ns of 
the majo r and minor axes as the diameter of the ge l. All experiments were 
carricd out in quadrup ti catc. 
Statistical Analysis Data were elltered in a computerized statistica l 
ana lysis program (In Stat; GraphPAO Software. San Djego. CAl . T ir e 
Student' s t test and one-way analysis of vari ance tcst were used for 
paranlctric results. w he reas linear regressio n analysis \vas c tnploycd to 
dcternl ill c correJation cocffi c ients (r). Statistical sig nifi cance was defined as 
a p value of 0.05 o r less. 
R E SULTS 
In con t rast to th e initial hypoth esis that TGF-{31 p layed an impo r-
ta n t ro le in the d evelopm ent of n eopl asia, it was later fo und th at, 
fo r the m ost part, thi s and other TGF- {3 isoforms actua lly inhi b it 
pro li fe ration of m an y ty pes of cells, including e nd oth e lia l and 
epith e lial ce ll s. Fibroblast growth, h owever, is generall y stimulate d 
b y TGF-{3's (Cox, 1995). In agreement with th ese e al· li e r o b ser va-
tion s, we fo und t h ,1t TGF-{33 (0.1 to 100 pg per ml ) e n han ced DNA 
synthes is in hum an d e rmal .fibroblast c ul tures b y 1110 re than 50% 
(p < 0.0 1) in a co n centration-de p ende nt m a.l1l lCr (Fig 1; r = 
0.970). DNA synth es is was maximally stimul a te d a t a pproximate ly 
100 pg of TGF-{33 p er ml , with n o furth er in c reases o b served at 
high e t· concentratio n s (1 to lOng pet· 1111 ; data not shown). We next 
d e te rmine d th e eHeet ofTGf- {33 o n collagen o u s protein . T his was 
d o n e by m easuring [3H]-proline incorpo ratio n in to pepsin-resistant 
sa lt-precipitable extracellula r co ll agen. Figure 2 shows a represen-
tative experime n t in w hich a con centra tion-depell dent (r = 0.9 90). 
up to 2-fo ld incre ase (p < 0.001) in coll agen synth esis was 
me,lsured in re spon se to TGF-{33 (0 .1 to lOng per ml). M aximal 
inc rease in co ll agen syn th esis was o b served be tween 1 and 5 n g of 
TGF-{33 pe r ml and, as is sh own in Fig 2, the level of stimulati o n 
was s imil ar to th at observed with 5 n g of TGF-t31 pe r m l. 
T h e re fore, the a bo ve results show that TGF- {33 stimulates both 
fibroblast DNA synthesis and coll agen production . We n ext tes ted 
TGF-t33 in an ill " i/m m o d el of collagen contra ction in w hich 
fibroblasts contrac t a co llagen gel (Tin gs tro m et a/, 1992; Dans an d 
I sseroft~ 1994) . We p re pared collagen latti ces (ge ls) by seed ing 
human d ermal fibroblasts in ;l solution of type I collagen (10) . First. 
w e dc termined th e cellnllmbe r required for o p t imal gel con tra c t io n 
(data not shown) . W e th en exp osed co llagen gels to 15 n g of e ith e r 
TGF- {3 1, {33, o r c o n tro l medium (M C DB '105) p e r ml. As sh own in 
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F igurc 4 . T G F -{B inc r c a scs proc oJlagcn a nd T GF-/31 mRNA Icv-
c Is . Human derm al fib ro blast cultures wc re trea ted w ith TGF-{33 fo r 24 h 
in DMEM plus I O'/'o F\3S. T he graph shows densito m etri c readings fo r 0'1 (I ) 
proco ll agc lI. 0' 1 (III ) proco llagcn . and TGF-{3 I . which arc no rmali zed fo r 
GA PD H . 
F ig 3 , TGF-{33 in creased gel contrac ti on as earl y as 24 h , and by 
alm ost 100% (p < 0.00 1) at day 5 . T hi s earl y effect o n gel 
contraction arg ues aga in st bu t does not exclude the possibility that 
the effect m ay be m edi ated in part by increased fi brobl ast pro life r-
ation. T he ge l con trac tio n ca used by the two TGF-{3 isofo r111 s was 
rem arka bly com parabl e in this assay. W e nex t de termin ed whethe r 
the stimul ation of coll agen synth esis by TGF- {33 occurs at th e 
mRN A level. W e ex posed human dermal fibro blasts to concentra-
tio ns of TGF-{33 rang in g fi 'om 0. 1 to 10 ng pe r ml and fo und that 
TGF-{33 cau ses a dose-dependen t (I' = 0.990) m ore than 2-fold 
in crease in 0'1 (I) procollagen mRN A leve ls (F ig 4) . As with the 
m easure m ents of co Ll ageno us prote in syn thesis. m ax imal stimul a-
tion of p rocoll agen mRN A was o bserved between 1 and 5 ng per 
ml of TGF-{33. In these and in subseq uen t expe riments, it was 
noted that TGF-{33 leads to the coordin ate upregul atio n of both 
0'1 (I) and 0'1 (HI ) proco ll agen mRNA. T he tig h t co-regul atio n o f 
these two co ll agen genes has been previo usly described (1.3). 
Up regu lation by TGF- {33 of mRN A levels of 0'1 (1) , 0'1 (III) 1'1'0-
coll agen, and TGF- f31 w as fo und in five diffel'en t experim ents and 
was maxim al 24 h afte r th e additio n o f TGF-{33 (F ig 5) . 
O ur res ul ts in d ic,lte tha t TGF- {33 in creases both pJ'Ocollagen and 
TGF-{31 mRNA leve ls. 'W e there fo re became in te res ted in know-
ing the m echani sm s by w hich TGF- {33 stimul ates co llagen p rodu c-
tio n and w hethe r they arc dependen t o n the actio n ofTGF-{31 . W e 
approached this questio n in two ways. W e first used a TGF- {31 
anti-sense o li gon ucleotide, w hi ch is specifi c fo r the TGF- {31 iso-
fo rm , to bloc k TGF-{31 transcl'ipti on in hum an de rmal fibro bl ast 
cul tures treated w ith TGF-{33. T he 19 m er TGF-{31 an ti-sense 
o ligonucleotide used in th ese experim en ts ha s been sho wn pre vi-
o usly to block the action ofTGF-{31 ;11 11 ;'10 (Brunet ef (/ / , 1995). As 
sho wn in F ig 6, in creasin g concen tratio ns (0. 1 to '10 J-LM) of this 
an ti-sense oli gonu cleo tide ca used a progressive decrease (mo re 
~ 
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F igurc 5. TGF -{33 s timulates procollagen mRNA Icvels ill a time _ 
d c pcndent ll1al1ncr. Human de rmal fi bro blast cul tures we re incubated in 
D M EM p lus 10'X, FBS w ith or w itho m 5 ng ofTGF-{33 per ml. T he graph 
shows densi tometri c rcadings fo r cYi ( I) I roco llagen ml"t.N A levels no rmal_ 
ized (,)r the ex press ion of GAPDH . 
than 50'X,) in the stimula to ry e ffect o f TGF-{33 o n 0'1 (I) proco llagen 
mRN A levels (I' = 0.958). Sense o ligonu cleo tide (1 0 J-LM ) had no 
such inhibitory effect and indeed m ay have ca used a sm all in crease 
in procollagen mRNA leve ls (Fig 6) . 
T he second approach we used to determine the direct effect of 
TGF- {33 was to test this isoform ill a sys tem devo id ofTG F-{31. For 
thi s purpose . we cultu red fibro bl as ts fro m TGF-f31 kn ock- o ut mj ce 
(Kulkami ef (/ /, 1993) and con trol li tte rm ates . As expected , kn ock-
o ut cell s had no mRNA signal fo r T G F-{31 (not sho wn). U sing 
th ese two sets o f cells, we fo und that TG F-,i33 is indeed capable of 
stimul atin g collagen synthes is on its o wn , in the absence of the {31 
iso fo rm . T hu s, wh en added to dermal fi broblas ts derived ti'om 
TGF-,i31 kn ock-o ut mice, TGF-{33 was still able to e nhance 0'1 (I) 
proco Uagen mRNA leve ls (Fig 7; r = 0.863 ). It should be po inted 
o ut th at in th ese and in other unrelated experim ents w e have fo und 
that kn ock-ou t fibro bla sts show a greater base lin e synth esis of 
co llagen than the ir wild- type coun te rpar t. The reasons fo r thjs 
un expected an d parado xical e ffect are still uncl ea r to us, but the 
m ay represent adju stm en ts o r compensato ry mechan.isl11s taking 
place in the absence of T GF-{31 stimulatio n. There fore, collagen 
synthesis is not controll ed by TG F-{31 alo ne, and the e ffects o f o th er 
g ro wth factors ma y be m o re pro min en t in T GF-{3 kn ock-o ut ce Li s. 
All of th e results presented thu s ta r indica te that TG F-{33 . like the 
,131 and {32 iso fo rms, increases collagen syn thesis, 0'1 (1) and al (III) 
proco llagen mRN A levels, and collagen ge l contra ctio n. Our 
results also sho w that TG F- {33 in creases collagen synth esis thro ugh 
TG F-{31 de pendent and independent mechanism s. T hese observa-
tio ns sugges t th at TG F- {33 could perhaps contro l the exten t of 
collagen depositi on by shifting fro m a TGF-,i31 dependent to 
independent pathway . It is unlike ly , ho we ver. that TGF- {33 acts 
alo ne ;11 11 ; 110, becau se release ofTGF- {31 by pl ate lets and other cells, 
includin g m 'lcro phages, is a fund am en ta l event during ti ssue inju ry. 
W e there fol'e hypoth esized th at th e interacti ons betw een TGF- 133 
with {31 mi ght contro l the e xtent of co llagen productio n and asked 
specifi cally whe th er in creasin g concentratio ns of T GF-{33 could 
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Figure 6. TGF- fll anti-sense oligonucleotide decreases the stimu-
latory effect ofTGF-/33 on a 1(1) procollagen mRNA. Human derma l 
fibroblast cultures were first exposed for 24 h to increas ing concentrations 
of a 19 mer TGF-f31 anti-sense oligonucleotide in se rum-fTec med ium. 
Cultures were then either left untreated again or exposed for an additional 
24 h to TGF-f33 and to sense oligonucleotide, which served as an additiona l 
control. The graph shows densitometric anal ys is of cr l (I) procollagen 
normalized for GAPDH . 
block the sti mulatory effects of TGF-/31 011 co llagen production . 
Figure 8 shows first, in agreement with our earlie r results, th at 
TGF-/33 incl'eased mRNA for a l (1), al (III) proco Uagen , and 
TGF-/31 . Indeed, th e com bination of small amounts of TGF-/33 
(0 .1 per m l) with TGF-/31 were at least additive in stimulating 
procollagen and TGF-/31 mRNA levels. As is shown in Fig 8, 
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Figure 7. TGF-f33 is capable of stimulating a1(1) procollagen 
=RNA ill TGF-fl1 knock-ollt fibroblasts. Dermal fibroblasts (:i'om 
TGF-f31 knock-out mice (K) and cOl1tro l wild-type (W) litte rmates were 
treated overnight with increasing concentrations of TGF-f33 in serul11-fTe" 
medium. The graph represents densitometric readings normalized for 
GAPDH. 
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Figure 8. Simultaneous addition of TGF-/33 and TGF-f31 down-
regulates procollagell I11RNA levels . Human derl11al fibrob last cultures 
were incubated for 24 It in serum-free medium afte r the addition orTGF-f3 
isoforms. The graph represents th" densitol11etric readings for 0' 1 (I), cr l(I II ) 
procollagen. and TGF-f3 1. wh ich are 11 01111a lized for the expression of 
GAPDI-!. The x axis shows the ra tio of different concentrations of TGF-
f3 Land TG F-f33. 
however, we found a paradoxica l response to the combination of 
the two isoforms w hen we increased the concentration ofTGF- /33 . 
W hen added simul tan eo usly with TGF- /31, g reater amounts of 
TGF-/33 (1 and 5 ng per ml) caused a coordinate decrease toward 
baselin e of al (I) , al (1II) procollagen, and TGF-/31 mRN A levels. 
For this down regulati on to occur, the two isoforms must be added 
in close chrono logic sequence. T hus. no decrease in a l (I) o r a 
l(IlI) procollagen was observed when the two peptides w ere added 
24 h apart (data not sho w n). 
DI SCUSSION 
In this report. we show that TGF-/33 stimula tes DNA and total 
coll agen syn thesis and co llagen gel con traction and in creases 
mRNA levels of Cl' (I), a 1 (Ill) procolJagen , and TGF-/31 in 
cultures of human dermal fibroblasts . Our experimen ts indicate that 
TGF-/33 increases collagen synthesis through two pathways. on e 
requiring TGF-/31 transcription and th e othe r independent of this 
isofo rm . Moreover, we show that increasing con centrations of 
TGF- /33 b lock the stimulato ry efFects of TGF- /31. These observa-
tions indi cate that w h ereas TGF-/33 docs in crease collagen synthesis 
and transcription, it may have an important ro le in controlling the 
fibroti c efFects of TGF-!31 and in fine tuning the synth esis of 
extracellular matrix within the broad context of stimu larion by the 
TG F-/3 fa mily of peptid es. 
Soon afte r its discovery, TGF- /31 was shown to be an important 
m ediator of extracellul ar matl-Lx formation and has since been 
increasin gly implicated in th e development of fibrosis and scarring 
(Border and Noble, 1994). It has been repeatedly shown to in crease 
collagell synthes is and transcriptio n (Roberts and Sporn , 1993; 
Jimenez cl ai, 1994). Because it is stored in platelets and released by 
other cells, such as macrophages, TGF-/31 is ub iquitously present in 
re latively large concelltratio lls at sites of tissue injury and of many 
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inA ammatory processes characterized by platelet aggregation and 
release. Consequently, at least under normal physiologic condi-
tions, certain controls must be in place to prevent or redu ce the 
fibrotic efFects of TGF-/31. Activation of the TGF-/31 peptide, 
modulation of its cellular receptors, and binding of this isoform by 
matrix moleculcs and other proteins are some of the established 
mechanisms involved in controlling the action ofTGF-/31 once it is 
re leased in to the tissues (Roberts and Sporn, 1990, 1993; Cox, 
1995; H..oberts, 1995) . A role for specific TGF-/3 isoforms in 
downregulating or controlling the overa ll responses to TGF-{3 's is 
largely unstudied, althou gh autocrine controls are increasingly 
recognized as important ways to regulate the biologic activity of 
certain cytokines and growth factors (Sporn and Robcrts, 1992). 
T here is direct evidence, however, that TGF-/3 isoforms are not 
interchangea ble. For example, it was recently shown that inhibition 
ofTGF-/33 (but not TGF-/31 or /32) blocks normal mouse embryo 
palate fusion (Brunet e/ nl, 1995) . As another example, rescue from 
other TGF- /3 isofomls does not occur in TGF-/31 knock-out mice, 
w hich die shortly after birth (Ku lkarni, 1993). 
The in teractions described here be tween the /31 and {33 isoforms 
m ay h ave important implications for the synthesis of extracellular 
m atrix proteins and for controlling scarring and fibrosis. At least in 
part, o Ul· fi ndings provide an explanation for decreased scarring ;11 
Il;VO afte r the injection ofTGF-{33 in experimental rnt wounds (Shah 
el aI, 1995). Although TGF-/33 does stimulate collagen synthesis, it 
is able to block the stimulatory effects of TGF-{3l on al (I) and 
al (III) procollagcn mRNA levels. Interactions between TGF-{33 
al]d TGF-{31 occur in many ;11 1l ; IlO situations, including wound 
repair. In addition to being released from plate lets, its primary 
storage site, TGF-/31 is abundant in wounds for other reasons. T he 
proteolytic environment ch aracteristic of wounds can serve to 
activate the peptide o r release it from its stores in extracellular 
matrix o r fi:om the clot formed shortly after wounding (Cox, 1995) . 
Transcription of the TGF-{31 gene in the epidermis and dermis is an 
ea rl y event after injury, and disruption of the basement membrane 
may provide additional signals for TGF-/31 synthesis (Border and 
Noble, 1994). W hile exogenous administration of TGF-/33, as 
described in previous reports (Shah el nl, 1995), most probably leads 
to in teractions between tills and the TGF-{31 isoform in wounds, 
there is also experimental evidence that endogenous TGF-/33 is an 
important player after tissue injury. TGF-{33 is the only isoform that 
is constitutively expressed in intact human epidemlis, and it is 
detected during wound healing in the migra ting epidennis of 
full-thi ckness human wounds (Border and Noble, 1994). T here-
fore, there are many opportunities for TGF-/31 and TGF-/33 to 
in teract ;11 11;110, making it possible that the type of control demon-
strated here for TGF-/33 could help regulate the overall .fibrotic 
response. At tills point we don 't know how TGF-/33 enhances 
coll agen synthesis and whether, in its TGF-/31 -independent mode, 
it uses the same mechanisms operative for TGF-/31. 
We have shown that TGF-{33 enhances collagen synth esis 
through TGF-/31-dependent and -independent mechanisms of 
action and that it caD downregulate an d limit the action ofTGF-/3l. 
T Ills isoform-based and isofoml-specific dampening of a biologic 
response may be a w idely operative mechanism for controlling the 
action of TGF-{3's. 
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